
Maksymilian Świniarski
President of the Management Board (CEO)
A leader with extensive professional experience in business and project management. He has been actively involved in the pharmaceutical industry for over 20 years, working for some of the world’s largest biotechnology corporations. In those roles, he held key positions that enabled him to acquire the knowledge and skills essential for managing a dynamically developing company such as ours. Within organisations such as Bayer, Eli Lilly Polska, AstraZeneca, and Synthaverse, he was responsible for introducing medicines to the market and successfully implementing product development strategies in the fields of diabetology, oncology, cardiology, and psychiatry.

